Is the PPWR Exemption for Pharmaceutical Packaging a “Breathing Space” or a “Countdown”?

On August 26, 2026, the European Commission officially confirmed that packaging in direct contact with medicinal products, as well as outer packaging necessary to ensure the quality of such products, is exempt from the PPWR’s requirements regarding recyclability and recycled plastic content.
The rationale is clear—medicinal product packaging is an integral part of the marketing authorization, and patient safety is the primary consideration.

However, for manufacturers of medicinal product packaging, this is a warning sign rather than a reason to let their guard down.
The exemption is time-limited and will be reviewed in 2035.
The European Commission has made it clear that this exemption is not permanent and will be reviewed by January 1, 2035, to determine whether it remains justified.

There are less than nine years remaining until 2035.
For the pharmaceutical packaging industry, a nine-year transition period may seem long, but considering the complex processes involved in modifying pharmaceutical packaging—such as re-certification, stability studies, and applications for marketing authorization amendments—this window is actually much shorter than it appears.

Implications for pharmaceutical packaging manufacturers:

👉 Implication 1: 2035 is not the end point, but the starting point of the countdown. If you wait until 2034 to begin planning for sustainable packaging solutions, you will face: material R&D, process validation, stability studies, and marketing authorization variation applications—a process that takes at least 3–5 years. By then, it will be too late to act.

👉 Insight 2: Planning for sustainable packaging in advance is the optimal strategy for hedging against future policy risks. The policy direction is clear: sustainability is the ultimate goal, and exemptions are only temporary detours.

👉 Insight 3: The value of China’s supply chain is becoming increasingly evident. The core challenge in transitioning pharmaceutical packaging toward sustainability lies in materials—achieving recyclability or compostability while ensuring barrier properties, stability, and sterility. China is precisely one of the world’s fastest-growing and most cost-competitive suppliers in areas such as compostable materials, bio-based materials, and high-barrier packaging materials.

🌻 How We Can Help You 🌻
The value of China’s supply chain is undeniable, but with the EU’s increasingly complex and stringent regulations, finding suppliers that are compliant, reliable, and capable of delivering both cost-effective and high-quality products is a challenge every packaging manufacturer faces. And that is precisely where our value lies.

The PPWR exemption for pharmaceutical packaging is not the end goal, but rather the start of a countdown. Only by beginning to plan now can you be fully prepared when 2035 arrives.

For more professional insights and analysis, please visit my LinkedIn: linkedin.com/in/nan-sun-5a0341362

First, let's look at four project case studies on the application of recycled plastics in automobiles:

- PureCycle and Motherson have used 30% recycled PP in A‑surface bumper demonstrator parts.

- MATERI'ACT and Renault have gone a step further by achieving a closed‑loop production loop from "end‑of‑life vehicle bumpers → recycled PP → new vehicle instrument panels" at series-production scale. This demonstrates that post‑consumer plastics from scrapped vehicles can already re‑enter large visible interior components.

- Audi is using chemical recycling to process mixed automotive plastics that are difficult to separate mechanically, and is feeding the resulting recycled feedstock into the production of Q8 e‑tron seat belt buckle housings.

- BMW, meanwhile, is tackling the challenge from the component design side by reducing the variety of materials used in bumpers, increasing the proportion of mono‑materials and thereby enhancing downstream recyclability, so as to pre‑condition parts for better recovery after the vehicle's end‑of‑life.

These four cases illustrate that recycled PP used in automobiles is no longer confined—as in the past—to parts that are less visible, such as wheel arch liners, underbody shields and luggage‑compartment liners. The application of recycled plastics in the automotive sector is shifting from low‑requirement components towards high‑appearance‑quality, high‑performance, and closed‑loop production‑scale applications.

In addition to technological feasibility driving this shift, the policy side has now added the most significant weight to this trend.

On 24 July 2026, the Official Journal of the European Union formally published the new End‑of‑Life Vehicle Regulation (Regulation (EU) 2026/1738), which for the first time incorporates mandatory minimum recycled‑plastic content into the vehicle compliance framework. The core quantitative targets are clear:

- From September 2032, at least 15 % of the plastics used in new vehicle types must come from post‑consumer waste, of which at least 20 % (i.e. 3 percentage points of the vehicle's total plastic) must originate from closed‑loop ELV (End‑of‑Life Vehicle) sources;

- This is further tightened from 2036, when the minimum recycled‑plastic content rises to 25 %, with the closed‑loop ELV share increasing correspondingly to 5 percentage points;

- Chemical recycling is formally recognised as a compliance pathway, and mass‑balance accounting is introduced in parallel, opening a regulatory channel for the recovery of mixed automotive plastics.

Regulation is driving demand, while technology determines supply. The four examples demonstrate that the industry is already pre‑positioning capabilities ahead of the compliance deadlines. For both vehicle manufacturers and automotive parts suppliers, securing a stable and reliable supply chain for recycled plastics is now a matter that requires immediate strategic planning.